Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Health Related Quality of Life in Juvenile-Onset Systemic Lupus Erythematosus: A Questionnaire-Based Study
Riham Eid1, Ayman Hammad2, Mai S Korkor2
1Pediatric Nephrology Unit, Faculty of Medicine, Mansoura University Children's Hospital, Mansoura University, Mansoura, 35561, Egypt. rihameid@mans.edu.eg.
Insights
Egyptian children with systemic lupus erythematosus (SLE) experience lower health-related quality of life (HRQOL). Disease activity and cumulative steroid use significantly impact HRQOL, highlighting the need for effective disease management.
Area of Science:
- Pediatric Rheumatology
- Quality of Life Research
- Clinical Assessment Tools
Background:
- Systemic lupus erythematosus (SLE) significantly impacts children's health-related quality of life (HRQOL).
- Evaluating HRQOL in pediatric SLE is crucial for comprehensive patient care.
- Standardized tools are needed to assess HRQOL in diverse populations.
Purpose of the Study:
- To evaluate HRQOL in Egyptian children diagnosed with SLE.
- To compare HRQOL using three distinct assessment tools: PedsQL™ 4.0 Generic Core Scales (GCS), PedsQL™ 3.0 Rheumatology Module (PedsQL3-RM), and the Simple Measure of the Impact of Lupus Erythematosus in Youngsters (SMILEY).
- To identify factors associated with diminished HRQOL in this cohort.
Main Methods:
- A questionnaire-based study involving 100 Egyptian children with SLE.
- HRQOL assessed using PedsQL™ 4.0 GCS, PedsQL3-RM, and SMILEY.
- Disease activity measured by SLE disease activity index (SLEDAI) and chronic damage by SLE International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).
Main Results:
- Pediatric SLE patients demonstrated significantly lower HRQOL scores across most PedsQL™ 4.0 GCS and PedsQL3-RM domains compared to normative data.
- The SMILEY tool indicated a low overall HRQOL, with "Burden of SLE" scoring the lowest.
- Factors such as longer disease duration, higher cumulative steroid doses, elevated SLEDAI and SDI scores, and obesity were strongly associated with poorer HRQOL outcomes across all three instruments (p < 0.001).
Conclusions:
- The Arabic versions of PedsQL™ 4.0 GCS, PedsQL3-RM, and SMILEY are user-friendly and interpretable for Arabic-speaking populations, suitable for frequent HRQOL monitoring in SLE children.
- Effective management of SLE disease activity and minimizing steroid dosage are paramount for enhancing the quality of life in children with SLE.
- These validated tools can aid clinicians in monitoring and improving the HRQOL of pediatric SLE patients.
Objectives:
This study aimed to evaluate health related quality of life (HRQOL) in Egyptian children with systemic lupus erythematosus (SLE) using 3 different tools.
Methods:
In this questionnaire-based study, 100 children with SLE were included. HRQOL was assessed using the Pediatric Quality of Life Inventory Generic Core Scales (PedsQL™ 4.0 GCS), PedsQL™ 3.0 Rheumatology Module (PedsQL3-RM) and the Simple Measure of the Impact of Lupus Erythematosus in Youngsters (SMILEY). SLE disease activity index (SLEDAI) was used to evaluate activity and SLE International Collaborating Clinics/ American College of Rheumatology Damage Index (SDI) was used to evaluate chronic damage.
Results:
All mean scores of PedsQLTM4.0 GCS domains in SLE patients were lower than published normative data and previously published results of Egyptian healthy controls (p < 0.001). All mean scores of PedsQL-3RM domains were significantly lower than published normative data except for the treatment and pain and hurt domains (p = 0.1, 0.2 respectively). SMILEY scores were low and the lowest domain scores was "Burden of SLE". Longer duration of illness, higher cumulative steroid doses, higher SLEDAI and SDI scores and presence of obesity were associated with lower scores for all 3 tools (p < 0.001).
Conclusion For Practice:
The Arabic copies of PedsQL™ 4.0 GCS, PedsQL3-RM and SMILEY are easily used for Arabic speaking subjects and easily interpreted by physician and can be implemented for frequent monitoring of SLE HRQOL. Controlling the disease activity and using lowest doses of steroids and other immunosuppressive drugs are the corner stone strategies for improving HRQOL in SLE children.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome III : Nursing Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Rheumatic Heart Disease I: Introduction

